BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30252131)

  • 21. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer.
    Sui H; Zhao J; Zhou L; Wen H; Deng W; Li C; Ji Q; Liu X; Feng Y; Chai N; Zhang Q; Cai J; Li Q
    Cancer Lett; 2017 Sep; 403():86-97. PubMed ID: 28602978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. VEGF-C induced by TGF- β1 signaling in gastric cancer enhances tumor-induced lymphangiogenesis.
    Pak KH; Park KC; Cheong JH
    BMC Cancer; 2019 Aug; 19(1):799. PubMed ID: 31409309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tamoxifen decreases extracellular TGF-beta1 secreted from breast cancer cells--a post-translational regulation involving matrix metalloproteinase activity.
    Nilsson UW; Jönsson JA; Dabrosin C
    Exp Cell Res; 2009 Jan; 315(1):1-9. PubMed ID: 18996114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
    Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB
    Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxia-induced retinal pigment epithelium cell-derived bFGF promotes the migration and angiogenesis of HUVECs through regulating TGF-β1/smad2/3 pathway.
    Chen W; He S; Xiang D
    Gene; 2021 Jul; 790():145695. PubMed ID: 33964379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. β-Galactoside α2,6-sialyltranferase 1 promotes transforming growth factor-β-mediated epithelial-mesenchymal transition.
    Lu J; Isaji T; Im S; Fukuda T; Hashii N; Takakura D; Kawasaki N; Gu J
    J Biol Chem; 2014 Dec; 289(50):34627-41. PubMed ID: 25344606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TGF-β1 secreted by Tregs in lymph nodes promotes breast cancer malignancy via up-regulation of IL-17RB.
    Huang SC; Wei PC; Hwang-Verslues WW; Kuo WH; Jeng YM; Hu CM; Shew JY; Huang CS; Chang KJ; Lee EY; Lee WH
    EMBO Mol Med; 2017 Dec; 9(12):1660-1680. PubMed ID: 28993429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein sialylation by sialyltransferase involves radiation resistance.
    Lee M; Lee HJ; Bae S; Lee YS
    Mol Cancer Res; 2008 Aug; 6(8):1316-25. PubMed ID: 18708363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MUC1 in human and murine mammary carcinoma cells decreases the expression of core 2 β1,6-N-acetylglucosaminyltransferase and β-galactoside α2,3-sialyltransferase.
    Solatycka A; Owczarek T; Piller F; Piller V; Pula B; Wojciech L; Podhorska-Okolow M; Dziegiel P; Ugorski M
    Glycobiology; 2012 Aug; 22(8):1042-54. PubMed ID: 22534569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dihydroartemisinin inhibits the tumorigenesis and metastasis of breast cancer via downregulating CIZ1 expression associated with TGF-β1 signaling.
    Li Y; Zhou X; Liu J; Gao N; Yang R; Wang Q; Ji J; Ma L; He Q
    Life Sci; 2020 May; 248():117454. PubMed ID: 32088211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of TGF-β1 Pathway by SCUBE3 Regulates TWIST1 Expression and Promotes Breast Cancer Progression.
    Yang X; Hu J; Shi C; Dai J
    Cancer Biother Radiopharm; 2020 Mar; 35(2):120-128. PubMed ID: 31742430
    [No Abstract]   [Full Text] [Related]  

  • 32. Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells.
    Ciccone V; Terzuoli E; Donnini S; Giachetti A; Morbidelli L; Ziche M
    J Exp Clin Cancer Res; 2018 Dec; 37(1):311. PubMed ID: 30541574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversible sialylation: synthesis of cytidine 5'-monophospho-N-acetylneuraminic acid from cytidine 5'-monophosphate with alpha2,3-sialyl O-glycan-, glycolipid-, and macromolecule-based donors yields diverse sialylated products.
    Chandrasekaran EV; Xue J; Xia J; Locke RD; Matta KL; Neelamegham S
    Biochemistry; 2008 Jan; 47(1):320-30. PubMed ID: 18067323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.
    Pousset D; Piller V; Bureaud N; Monsigny M; Piller F
    Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer.
    Busch S; Acar A; Magnusson Y; Gregersson P; Rydén L; Landberg G
    Oncogene; 2015 Jan; 34(1):27-38. PubMed ID: 24336330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exosomal transfer of vasorin expressed in hepatocellular carcinoma cells promotes migration of human umbilical vein endothelial cells.
    Huang A; Dong J; Li S; Wang C; Ding H; Li H; Su X; Ge X; Sun L; Bai C; Shen X; Fang T; Li J; Shao N
    Int J Biol Sci; 2015; 11(8):961-9. PubMed ID: 26157350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PFKFB3 is involved in breast cancer proliferation, migration, invasion and angiogenesis.
    Peng F; Li Q; Sun JY; Luo Y; Chen M; Bao Y
    Int J Oncol; 2018 Mar; 52(3):945-954. PubMed ID: 29393396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuous taurocholic acid exposure promotes esophageal squamous cell carcinoma progression due to reduced cell loss resulting from enhanced vascular development.
    Sato S; Yamamoto H; Mukaisho K; Saito S; Hattori T; Yamamoto G; Sugihara H
    PLoS One; 2014; 9(2):e88831. PubMed ID: 24551170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD151 promotes breast cancer metastasis by activating TGF-β1/Smad signaling pathway.
    Zhao SJ; Zhao HD; Li J; Zhang H; Gao DT; Wang Q
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7314-7322. PubMed ID: 30468476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidative damage and response to Bacillus Calmette-Guérin in bladder cancer cells expressing sialyltransferase ST3GAL1.
    Severino PF; Silva M; Carrascal M; Malagolini N; Chiricolo M; Venturi G; Barbaro Forleo R; Astolfi A; Catera M; Videira PA; Dall'Olio F
    BMC Cancer; 2018 Feb; 18(1):198. PubMed ID: 29454317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.